Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07890220Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of dexamethasone in adolescent idiopathic scoliosis (AIS) (3 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Cumulative Intravenous Fentanyl Consumption at 48 hours. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07890220.